Abdominal Sepsis: An Update.

J Crit Care Med (Targu Mures) 2018 Oct 1;4(4):120-125. Epub 2018 Oct 1.

University of Medicine, Pharmacy, Sciences and Technology of Târgu Mureş, Târgu Mureş Romania.

Despite the significant development and advancement in antibiotic therapy, life-threatening complication of infective diseases cause hundreds of thousands of deaths world. This paper updates some of the issues regarding the etiology and treatment of abdominal sepsis and summaries the latest guidelines as recommended by the Intra-abdominal Infection (IAI) Consensus (2017). Prognostic scores are currently used to assess the course of peritonitis. Irrespective of the initial cause, there are several measures universally accepted as contributing to an improved survival rate, with the early recognition of IAI being the critical matter in this respect. Immediate correction of fluid balance should be undertaken with the use of vasoactive agents being prescribed, if necessary, to augment and assist fluid resuscitation. The WISS study showed that mortality was significantly affected by sepsis irrespective of any medical and surgical measures. A significant issue is the prevalence of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae in the clinical setting, and the reported prevalence of ESBLs intra-abdominal infections has steadily increased in Asia. Europe, Latin America, Middle East, North America, and South Pacific. Abdominal cavity pathology is second only to sepsis occurring in a pulmonary site. Following IAI (2017) guidelines, antibiotic therapy should be initiated as soon as possible after a diagnosis has been verified.

Download full-text PDF

Source
http://content.sciendo.com/view/journals/jccm/4/4/article-p1
Publisher Site
http://dx.doi.org/10.2478/jccm-2018-0023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296273PMC

Still can't find the full text of the article?

We can help you send a request to the authors directly.
October 2018
25 Reads

Publication Analysis

Top Keywords

abdominal sepsis
8
antibiotic therapy
8
initial measures
4
esbl-producing enterobacteriaceae
4
enterobacteriaceae clinical
4
irrespective initial
4
measures universally
4
clinical setting
4
β-lactamase esbl-producing
4
prevalence extended-spectrum
4
contributing improved
4
accepted contributing
4
extended-spectrum β-lactamase
4
universally accepted
4
peritonitis irrespective
4
course peritonitis
4
prognostic scores
4
intra-abdominal infections
4
infections steadily
4
2017 prognostic
4

Similar Publications